Cerity Partners LLC Raises Stake in Relx Plc (NYSE:RELX)

Cerity Partners LLC raised its holdings in shares of Relx Plc (NYSE:RELX - Free Report) by 33.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 144,255 shares of the technology company's stock after acquiring an additional 36,181 shares during the period. Cerity Partners LLC's holdings in Relx were worth $7,272,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Bank of America Corp DE lifted its stake in shares of Relx by 4.2% in the 4th quarter. Bank of America Corp DE now owns 6,246,462 shares of the technology company's stock valued at $283,714,000 after purchasing an additional 253,107 shares during the period. Lazard Asset Management LLC raised its position in Relx by 1.2% during the fourth quarter. Lazard Asset Management LLC now owns 4,224,334 shares of the technology company's stock worth $191,868,000 after acquiring an additional 48,793 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of Relx by 4.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,189,886 shares of the technology company's stock worth $144,885,000 after buying an additional 121,831 shares in the last quarter. Ameriprise Financial Inc. grew its holdings in shares of Relx by 368.7% during the fourth quarter. Ameriprise Financial Inc. now owns 2,807,038 shares of the technology company's stock worth $127,437,000 after buying an additional 2,208,119 shares in the last quarter. Finally, Northern Trust Corp grew its holdings in shares of Relx by 51.6% in the fourth quarter. Northern Trust Corp now owns 2,191,588 shares of the technology company's stock valued at $99,542,000 after purchasing an additional 745,532 shares during the period. 15.02% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the stock. Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a research note on Wednesday, April 16th. Wall Street Zen cut shares of Relx from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Finally, The Goldman Sachs Group initiated coverage on shares of Relx in a report on Wednesday, March 26th. They issued a "buy" rating on the stock. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy".

Relx Stock Performance

NYSE:RELX traded down $0.57 during midday trading on Friday, reaching $52.90. The stock had a trading volume of 814,913 shares, compared to its average volume of 754,873. The firm has a fifty day simple moving average of $53.65 and a two-hundred day simple moving average of $51.09. Relx Plc has a 12-month low of $43.45 and a 12-month high of $56.33. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. The stock has a market cap of $97.16 billion, a P/E ratio of 28.44, a P/E/G ratio of 3.49 and a beta of 0.83.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.